Filing Flows › Bio-Techne (TECH) › Q3 FY25
Bio-Techne (TECH) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed May 8, 2025
Bio-Techne (TECH) reported revenue of $316M for the third quarter fiscal 2025 (Q3 FY25), +4% from a year earlier and +6% from the quarter before. Operating margin was 12.2%, net earnings $22.6M (7.1% of revenue).
Bio-Techne, Q3 FY25: revenue $316M (+4% year over year), operating margin 12.2%, net earnings $22.6M, operating cash flow $41.1M. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $316M | +6% | +4% |
| Gross profit | $215M | +11% | +5% |
| Operating profit | $38.7M | -18% | -42% |
| Net earnings | $22.6M | -35% | -54% |
| Operating cash flow | $41.1M | -51% | -49% |
| Free cash flow | $31.0M | -60% | -52% |
What changed
Revenue was $316.2M in Q3 FY25, up 4% year over year and up 6% from the previous quarter. Consumables was the largest line at 82% of revenue. Consumables added $11.1M year over year (up 4%), 87% of the total change. Instruments declined 1%.
Gross margin was 67.9%, up 0.4 points from a year earlier. Operating profit was $38.7M, a 12.2% margin (down 9.8 points year over year). Operating profit fell $28.3M even though revenue rose $12.8M versus a year earlier, so costs grew faster than sales. Operating expenses grew 28% against revenue growth of 4%. The fastest-growing cost line was SG&A (+35%). Net earnings were $22.6M, down 54% year over year. The effective tax rate was 41.0%.
Operating cash flow was $41.1M (down 49% year over year), 182% of net earnings. Non-cash charges added back $27.6M of depreciation and amortization and $11.4M of share-based compensation. Working capital and other items used $20.4M. Capital expenditures of $10.1M left free cash flow of $31.0M.
Questions
What was Bio-Techne's revenue in the third quarter fiscal 2025?
Bio-Techne (TECH) reported revenue of $316M for the third quarter fiscal 2025 (Q3 FY25), +4% from a year earlier and +6% from the quarter before.
Was Bio-Techne profitable in the third quarter fiscal 2025?
Operating profit was $38.7M (12.2% of revenue) and net earnings $22.6M.
Source: Bio-Techne 10-Q on SEC EDGAR.